Stephen E. Henderson

University of Oklahoma — United States

Social Sciences · Social Sciences

7h-index406citations119works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Criminal Law and Evidence(29), Legal Systems and Judicial Processes(27), Law, Rights, and Freedoms(23), Epigenetics and DNA Methylation(12), RNA modifications and cancer(12)

Publications119 total

In Defense of Pardons
SSRN Electronic Journal·2025Open Access
Epigenetic investigation of multifocal small intestinal neuroendocrine tumours reveals accelerated ageing of tumours and epigenetic alteration of metabolic genes
2024Open Access
An Empirical Exploration of a Jury Veto <br>
SSRN Electronic Journal·2024Open Access
Zorro: Everyperson's Moral Vigilante
SSRN Electronic Journal·2024Open Access
The skill mix agenda and indemnity
BDJ·2023Open Access
Supplementary Table 2 from <i>EZH2</i>-Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication Stress
2023Open Access
Supplementary Table 3 from <i>EZH2</i>-Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication Stress
2023Open Access
Supplementary information from <i>EZH2</i>-Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication Stress
2023Open Access
Supplementary Figures and Legends from <i>EZH2</i>-Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication Stress
2023Open Access
Supplementary Table 3 from <i>EZH2</i>-Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication Stress
2023Open Access
Supplementary Figures and Legends from <i>EZH2</i>-Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication Stress
2023Open Access
Supplementary information from <i>EZH2</i>-Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication Stress
2023Open Access
Data from <i>EZH2</i>-Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication Stress
2023Open Access
Data from <i>EZH2</i>-Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication Stress
2023Open Access
Supplementary Table 1 from <i>EZH2</i>-Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication Stress
2023Open Access
Supplementary Table 1 from <i>EZH2</i>-Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication Stress
2023Open Access
Supplementary Table 2 from <i>EZH2</i>-Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication Stress
2023Open Access
Supplementary Table S3 from Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets
2023Open Access
Supplementary Table S4 from Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets
2023Open Access
Supplementary Table S4 from Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Kiel Brennan-Marquez(5), James M. Flanagan(3), Juan M. Funes(3), Laurence Wild(3), Nessa Carey(3), Chris Boshoff(3), Michel Tétu(2), Robert C. Steensma(2), Nicholas A. Salerno(2), Bernth Lindfors(1), Mercer Cook(1), Michael D. Cadwalader(1), Scott M. Harvey(1), Susan L. Pope(1), William W. Hogan(1), John Ballance(1), Jeff Bastian(1), Ashley C. Brown(1), Terry Callender(1), Judith Cardell(1)